Efficacy and Tolerability CVI (A 12-week, Double-blind, Randomised, Placebo-controlled, Multicentre Trial (CVI)

NCT00292435 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

202

Enrollment

INDUSTRY

Sponsor class

Conditions

Venous Insufficiency

Interventions

DRUG: Read vine leaf extract (AS 195)

Sponsor

Boehringer Ingelheim